Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
7.44
+0.03 (0.40%)
Apr 1, 2026, 4:00 PM EST

Knight Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
729600534525581624
Market Cap Growth
18.79%12.33%1.73%-9.66%-6.89%-8.22%
Enterprise Value
693.06579.27438.66438.02498.84514.09
Last Close Price
7.446.055.345.195.185.30
PE Ratio
--121.00133.50-32.44-19.9240.77
Forward PE
45.78201.67157.0679.24-82.43
PS Ratio
1.621.331.441.601.982.56
PB Ratio
0.950.780.670.700.700.74
P/TBV Ratio
0.970.790.680.750.720.78
P/FCF Ratio
10.888.9515.8015.0113.8015.31
P/OCF Ratio
10.588.7014.7214.6112.9213.99
EV/Sales Ratio
1.541.291.181.331.702.11
EV/EBITDA Ratio
13.0210.687.259.2223.1214.65
EV/EBIT Ratio
--246.5059.30-151.56-12.15-40.06
EV/FCF Ratio
10.348.6412.9712.5211.8412.60
Debt / Equity Ratio
0.100.100.060.090.090.05
Debt / EBITDA Ratio
1.441.440.821.453.601.17
Debt / FCF Ratio
1.161.161.461.981.851.00
Net Debt / Equity Ratio
-0.02-0.02-0.12-0.11-0.10-0.13
Net Debt / EBITDA Ratio
-0.32-0.32-1.53-1.80-3.70-3.09
Net Debt / FCF Ratio
-0.26-0.26-2.75-2.44-1.89-2.66
Asset Turnover
0.450.450.390.330.290.24
Inventory Turnover
2.092.092.021.901.891.99
Quick Ratio
1.391.392.262.201.871.99
Current Ratio
2.392.393.573.202.802.90
Return on Equity (ROE)
-0.57%-0.86%0.27%-2.80%-5.27%0.77%
Return on Assets (ROA)
-0.16%-0.23%0.77%-0.29%-4.01%-1.26%
Return on Invested Capital (ROIC)
-0.20%-0.30%1.02%-0.39%-5.23%-1.84%
Return on Capital Employed (ROCE)
-0.27%-0.27%0.88%-0.33%-4.56%-1.42%
Earnings Yield
-0.74%-0.83%0.75%-3.08%-5.02%2.45%
FCF Yield
9.19%11.17%6.33%6.66%7.25%6.53%
Buyback Yield / Dilution
1.84%1.84%5.61%6.46%7.73%5.65%
Total Shareholder Return
1.84%1.84%5.61%6.46%7.73%5.65%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.